2024 PBS post-market review framework

31 January 2024 - The 2024 post-market review framework is now available. ...

Read more →

Addressing the challenges of implementing a Health Technology Assessment Policy Framework in South Africa

13 August 2020 - South Africa's commitment to progressively achieve universal health coverage can lead to the effective and appropriate use ...

Read more →

Paying for value from costly medical technologies: a framework for applying value-based payment reforms

2 June 2020 - Innovative medical products offer significant and potentially transformative impacts on health, but they create concerns about rising ...

Read more →

ICER finalises 2020 updates to methods and public meeting procedures for value assessment framework

31 January 2020 - Reflecting experience with previous framework, benchmarking with other HTA groups, and input from more than 100 organisations ...

Read more →

NICE seeks feedback from users of the evidence standards framework for digital health technologies

23 September 2019 - Consultation on priority areas open to stakeholders until mid October. ...

Read more →

Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications

16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...

Read more →

As value assessment frameworks evolve, are they finally ready for prime time?

9 September 2019 - Value assessment frameworks have emerged as tools to assist health care decision makers in the United States ...

Read more →

ICER Proposes Updates to 2020 Value Assessment Framework Methods and Procedures

21 August 2019 - Reflecting experience with current framework, benchmarking with other HTA groups, and public input, proposals include new emphasis ...

Read more →

ICER's value framework and patient feedback: Q&A with Steve Pearson

15 August 2019 - ICER invites all patient organizations and the general public to attend a webinar to learn more ...

Read more →

Novel approaches to value assessment within the cost-effectiveness framework

20 June 2019 - The second plenary session focused on the need to move beyond conventional cost-effectiveness analysis of healthcare interventions ...

Read more →

Framework for the regulation of regenerative medicine products

21 May 2019 - The U.S. FDA has published four final guidance documents that are part of a comprehensive policy framework ...

Read more →

ICER seeks public input for 2020 value assessment framework

2 May 2019 - Accepting Open Input Through 10 June 2019. ...

Read more →

Comparative assessment of clinical benefit using the ESMO Magnitude of Clinical Benefit Scale version 1.1 and the ASCO Value Framework Net Health Benefit Score

19 December 2018 - To better understand the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) ...

Read more →

The use of MCDA in HTA: great potential, but more effort needed

18 April 2018 - The potential for multi-criteria decision analysis (MCDA) to support health technology assessment (HTA) has been much discussed, ...

Read more →

Decision components of NICE's technology appraisals assessment framework

10 April 2018 - The UK's NICE is an established health technology assessment agency. de Folter et al. present a ...

Read more →